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Abstract
Background: Administration of magnesium sulphate (MgSO4) to women with imminent preterm birth at <34 weeks
is an evidence-based antenatal neuroprotective strategy to prevent cerebral palsy. Although a Society of Obstetricians
and Gynaecologists of Canada (SOGC) national guideline with practice recommendations based on relevant clinical
evidence exists, ongoing controversies about aspects of this treatment remain. Given this, we anticipated managed
knowledge translation (KT) would be needed to facilitate uptake of the guidelines into practice. As part of
the Canadian Institutes of Health Research (CIHR)-funded MAG-CP (MAGnesium sulphate to prevent Cerebral
Palsy) project, we aimed to compare three KT methods designed to impact both individual health care
providers and the organizational systems in which they work.
Methods: The KT methods undertaken were an interactive online e-learning module available to all SOGC members,
and at MAG-CP participating sites, on-site educational rounds and focus group discussions, and circulation of
an anonymous ‘Barriers and Facilitators’ survey for the systematic identification of facilitators and barriers for
uptake of practice change. We compared these strategies according to: (i) breadth of respondents reached;
(ii) rates and richness of identified barriers, facilitators, and knowledge needed; and (iii) cost.
Results: No individual KT method was superior to the others by all criteria, and in combination, they provided richer
information than any individual method. The e-learning module reached the most diverse audience of health care
providers, the site visits provided opportunity for iterative dialogue, and the survey was the least expensive. Although
the site visits provided the most detailed information around individual and organizational barriers, the ‘Barriers and
Facilitators’ survey provided more detail regarding social-level barriers. The facilitators identified varied by KT method.
The type of knowledge needed was further defined by the e-learning module and surveys.
Conclusions: Our findings suggest that a multifaceted approach to KT is optimal for translating national obstetric
guidelines into clinical practice. As audit and feedback are essential parts of the process by which evidence to
practice gaps are closed, MAG-CP is continuing the iterative KT process described in this paper concurrent with
tracking of MgSO4 use for fetal neuroprotection and maternal and child outcomes until September 2015; results
are anticipated in 2016.
Keywords: Knowledge translation, Magnesium sulphate, Fetal neuroprotection, Preterm birth
* Correspondence: LMagee@sgul.ac.uk
2Department of Obstetrics & Gynaecology, University of British Columbia,
Vancouver, Canada
3Child and Family Research Institute, University of British Columbia,
Vancouver, Canada
Full list of author information is available at the end of the article
© 2015 Teela et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Teela et al. BMC Pregnancy and Childbirth  (2015) 15:347 
DOI 10.1186/s12884-015-0785-8
Background
Preterm birth is the leading cause of infant death, illness,
and disability in Canada and worldwide. Despite marked
improvements in survival rates of preterm infants, the
risk of neurodevelopmental impairment, including cere-
bral palsy (CP), is substantial (2–2.5/1000 live births)
and has not decreased over recent years [1, 2].
Magnesium sulphate (MgSO4) for fetal neuroprotec-
tion provides one of the first prenatal evidence-based
treatments to improve the neurodevelopmental out-
comes of children born at <34 weeks, [3–5] and inter-
national guidelines were quick to recommend this therapy
[6, 7]. However, unresolved controversies were recognized
[6]. First, high MgSO4 doses formerly used for tocolysis
were associated with neonatal hypermagnesemia, hypo-
tonia, resuscitation, and mortality [8], but no such effects
were seen when MgSO4 was used at lower doses for fetal
neuroprotection in the relevant trials or in subsequent
publications [9]. Second, the mechanism of MgSO4 action
was not understood. Third, the gestational age threshold
for optimal MgSO4 benefit in the neuroprotective trials
was not clear below <34 weeks. Finally, there were inad-
equate studies of long-term outcomes, although subse-
quent publications have been reassuring [10, 11].
It is recognized that knowledge translation (KT)
and mobilization is an iterative process, and that dis-
semination of information is usually not enough to
change practice or behaviour. In obstetrics, a notable
example of failing to bridge the gap between know-
ledge and practice was the 22-year lag between the
publication on antenatal corticosteroid use and the
National Institutes of Health consensus conference
and American College of Obstetricians and Gynecologists
(ACOG) Committee Opinion on the topic [12, 13].
We anticipated that effective uptake of MgSO4 use for
fetal neuroprotection would require an effective process
of ‘managed knowledge translation (KT)’, whereby evi-
dence is reviewed to avoid misinformation, individual
and institutional barriers to implementation are identi-
fied and overcome, and ‘real-world’ effectiveness and
safety are monitored [14–17]. Consistent with its mandate
[18] CIHR funded the MAG-CP managed KT project to
actively implement the relevant Canadian guidelines into
clinical practice [6], as done for pregnancy hypertension
guidelines in British Columbia [19].
MAG-CP is using a combination of active and pas-
sive KT methods to educate health care providers,
and to better understand their knowledge, beliefs and
practices related to the use of MgSO4 for fetal neuro-
protection and their organizational culture. This paper
focuses on three primary KT methods designed to
impact both individual health care providers and the
organizational systems in which they work: (i) an
interactive online e-learning module with opportunity
to identify potential barriers to uptake; (ii) site visits
to participating tertiary perinatal units of the Canadian
Perinatal Network (CPN) for discussion of the evidence
and potential facilitators and barriers; and (iii) circulation
of an anonymous survey at CPN sites for the systematic
identification of facilitators and barriers for uptake of
practice change. We sought to compare these three
strategies, highlighting the relative advantages and
disadvantages of each approach, in order to offer rec-
ommendations on timely and cost-effective KT imple-
mentation [15].
Methods
MAG-CP is a managed KT project approved in 18 of
Canada’s 23 tertiary perinatal units that are part of the
CPN. Central approval for MAG-CP was obtained from
both the University of British Columbia’s (H11-02214)
and at each site’s Research Ethics Board (see Additional
file 1: Table S2), for both KT activities and audit of
MgSO4 utilization and health outcomes through the
CPN and the Canadian Neonatal Follow-up Network
(CNFUN). Written consent was not required for con-
ducting educational activities as part of the educational
component of the project. All health care providers who
participated did so voluntarily as with any other educa-
tional activities in the hospital, and they voluntarily and
anonymously participated in the e-learning module and
the barriers & facilitators questionnaire.
MAG-CP aims to determine, for pregnancies at risk of
imminent preterm birth at <29 weeks, whether utilization
of MgSO4 for fetal neuroprotection: (i) can be increased
over 4 years to a pre-specified level of 80 %; (ii) is associ-
ated with the anticipated decrease in CP and ‘death or CP’
that was seen in RCTs; and (iii) is associated with an
acceptable safety profile for both mothers and babies/
children. The project focuses on babies at risk of be-
ing born at <29 weeks because (i) they are at highest
risk of CP; and (ii) they are those for whom maternal
interventions and maternal and perinatal outcomes
are collected directly by the CPN or through linkage
to the CNFUN that tracks neurodevelopmental out-
comes to three years of age. Outcome data collection
is ongoing.
In our initial year of activity, MAG-CP used three pri-
mary methods of KT: an interactive, online ‘e-learning
module’, visits to CPN sites participating in the MAG-
CP project [20], and a ‘Barriers and Facilitators (B&F)
Survey’ that was distributed and collected by each site’s
local team. This knowledge translation project, includ-
ing the design and timing of site visits and B&F ques-
tions, was informed by the concepts and principles of
Roger’s Innovation-Diffusion theory. These include ele-
ments of: the complexity of the innovation, characteristics
of adopters, communication channels, time considerations
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for adoption and uptake, and organizational character-
istics of the social system. At the individual level, the
process of behaviour change includes knowledge of the
innovation, persuasion for uptake, an individual deci-
sion for uptake and use at which point the innovation
is either accepted or rejected, implementation of the
innovation, and finally, confirmation in their decision
for uptake [21]. Our qualitative data collection and ana-
lyses were designed to reflect the consolidated criteria
for reporting qualitative research (COREQ) checklist [22].
 E-learning module
A commercially-managed e-learning module (Advan-
cingIn®) was created by the Central MAG-CP Team and
AdvancingIn® [23] to reach all health care professionals
in a widely dispersed Canadian clinical community. This
approach focused on cognitive learning and problem
solving for the individual related to MgSO4 for neuro-
protection, and principles in adult education that have
been effective in enhancing knowledge and confidence
in practice change [24–27].
The Module contained basic questions about the par-
ticipants’ characteristics, including hospital site (location
and size) and type of care provider/role in that hospital.
The content of the Module consisted of: (i) pre-test
questions and a survey (to stimulate recognition of
knowledge gaps and opinions), (ii) a concise summary of
relevant background and published evidence for the ef-
fectiveness of MgSO4 for fetal neuroprotection (includ-
ing the relevant SOGC Clinical Practice Guideline [6], a
summary of controversies and uncertainties, and other
relevant reading materials including each of the three
relevant meta-analyses [3–5]), (iii) case analyses (to test
application of knowledge and simulate situations found
in clinical practice), (iv) practice tools, such as pre-
printed orders for MgSO4 administration for fetal neu-
roprotection, a pocket card to distinguish ‘imminent’
from ‘threatened’ preterm birth, and an information
sheet about how to counsel a patient about the potential
benefits of MgSO4 as a neuroprotective agent (as many
are unfamiliar about the nature of the outcome of CP),
(v) post-test questions and a survey (designed to test
knowledge, identify any remaining gaps, and explore
opinions about knowledge and practice), (vi) a course
evaluation, and (vii) a discussion forum in which partici-
pants provided comments and views about MgSO4 use.
Details of participant characteristics (as above), and free-
text response questions from the discussion forum and
course evaluation (Additional file 2: Panel S1) were used
for analysis. (The effectiveness of the module as a learn-
ing tool will be reported separately.)
The link for the MAG-CP e-learning Module was ac-
tively disseminated by email to SOGC members from
Mar 11/2012 to Mar 10/2013 by AdvancingIn®, and to
MAG-CP sites by the Central MAG-CP Team. The
Module was accessible free of charge, and continuing
medical education points were offered for completion.
(On Mar 11/2013, the Module was migrated over to
the CPN website for ongoing use by those at MAG-
CP sites [28]).
Costs accounted for were related to the AdvancingIn®
invoice and did not include Central MAG-CP Team time.
 Site Visits at participating CPN sites
Small group discussions were planned by the Central
MAG-CP Team for the local team at each participating
site (Mar to Dec/12). This approach was designed to
both reinforce cognitive learning, and facilitate inter-
action, discussion, and problem solving at inter-
disciplinary and organizational levels, in order to address
beliefs, practices, and culture.
These on-site facilitated sessions were planned to
occur shortly after local approvals for the project were
in place. One Central Team member attended all visits
(LAM), always accompanied by at least one other Team
member (AS, DS, or MB). Local site members were
asked to complete the e-learning module prior to the
site visit, and to encourage their local health care practi-
tioners to do the same.
Sessions were planned to be 3–4 hours in duration in-
volving didactic and interactive components, with a flex-
ible agenda so that the local team could prioritize their
needs. Planned didactic material was comprised of a
presentation (ideally at grand rounds in obstetrics) of
the evidence about MgSO4 for fetal neuroprotection, the
national guideline and summary of recommendations
(2011) [6], and a synopsis of CPN and CNFUN methods
that would enable audit of the use of MgSO4 for fetal
neuroprotection and associated relevant outcomes. The
planned interactive component consisted of a small-
group discussion between the Central MAG-CP and
local teams to review points raised at the rounds or by
the local B&F Survey (see below), and identify potential
local barriers and facilitators to practice change.
Attendance, professional designation, and minutes of
the discussion were collected at each visit. A full report
was written within one week of the visit by the facilitator
in attendance at all visits (LAM). The Central and local
team members in attendance were given the opportunity
to revise the report which when final, was circulated to
the local site team.
Costs accounted for related to transportation, ac-
commodation, and printing of presentations and prac-
tice tools necessary for distribution to the attendees.
Time by members of the Central MAG-CP Team was
not included, as this was covered by academic
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research time as University of British Columbia
(UBC) employees.
 Barriers and Facilitators (B&F) Survey
An anonymous B&F survey was designed to explore
perceived barriers and facilitators of implementation
of MgSO4 for fetal neuroprotection (Additional file 1:
Table S3). This approach was chosen to determine
overall organization readiness and address potential
challenges, as well as identify knowledge gaps and
opinions. Site teams were encouraged to review their
own reports prepared by the Central MAG-CP Team
to stimulate reflection and action.
Individual, institutional, and social aspects of KT
were considered. The B&F survey was available in
English or French, in paper or electronic PDF format.
The B&F surveys were distributed to individuals in-
volved in the care of women eligible for MgSO4 for
fetal neuroprotection and their babies. Responses were
collected by each site team. Sites were encouraged to
make every attempt to complete the questionnaire
prior to, or within three months following, the site
visit, and then every six months thereafter. Data pre-
sented here are from each sites’ baseline survey.
Costs were considered to be negligible, related to
printing of the two-page surveys if an electronic PDF
was not used to capture responses. As local team mem-
bers were hospital employees, their time was not in-
cluded in costing.
 Analyses
NVivo qualitative research software (QSR International
Pty Ltd. Version 10, 2012) was used to organize, analyze,
and interpret data from the three KT methods. Data,
which included descriptive information about respon-
dents, were coded and stored as nodes within NVivo,
which were subsequently used to explore similar and dis-
parate themes that emerged between the formats.
Qualitative research is an iterative and malleable
process, with coding and nodes consistently refined
throughout the analysis. Due to the possibility of intro-
ducing bias by a member of the central MAG-CP team,
two independent reviewers (KC and then KCT) con-
ducted the analyses. To further validate the analyses, a
blind-coding of the Barriers & Facilitators Survey was
conducted by a member of the central MAG-CP team
(DAD) to identify discrepancies. The results of this ac-
tivity showed that themes were consistent (Additional
file 1: Table S4), and thereafter, the remainder of the
analyses were carried out by the independent reviewers.
Findings were divided into three main categories: bar-
riers to implementation, facilitators to implementation,
and knowledge needed (for respondents to more com-
fortably and easily implement the intervention). To
better interpret themes and implications, barriers and
facilitators were divided into three basic categories:
individual-level, institutional-level, and social-level. The
final list of coding nodes is shown in Additional file 1:
Panel S2 and Additional file 1: Panel S3. Graphical and
tabular representations of the findings were created from
the emerging patterns and themes according to province
or health care provider, as well as size of the tertiary centre.
Results
In the first year of MAG-CP activity (March 2012–3),
14/18 sites contributed to this assessment of initial KT
activity for the site visits and B&F survey: Women’s
Health Program (Newfoundland), IWK Health Centre
(Nova Scotia), The Moncton Hospital, Saint John Regional
Hospital, and Dr. Everett Chalmers Hospital (New
Brunswick), Centre Hospitalier de l’Universite Laval
(Quebec), Mount Sinai Hospital, Sunnybrook Health
Sciences Centre, Saint Joseph’s Health Centre, and
The Ottawa Hospital (Ontario), Royal University Hospital
(Saskatchewan), Foothills Medical Center, and the Royal
Alexandra Hospital (Alberta), and British Columbia
Women’s Hospital and Health Centre (British Columbia).
Two additional centres had participants complete the
e-learning module only: Regina General Hospital
(Saskatchewan) and Victoria General Hospital (British
Columbia).
 Methods of KT utilized
In the first year of MAG-CP, 8/18 sites utilized all three
methods of KT, 6/18 utilized two methods (3 e-learning
module and site visit, 1 e-learning module and B&F sur-
vey, and 2 site visit and B&F survey), 2/18 sites used only
the e-learning module, and 2/18 used none of the KT
methods offered.
The e-learning module was completed by staff at
14/18 MAG-CP sites, with representation from all
major regions in Canada except for the Northwest
Territories and Nunavut.
The 10 site visits covered 13/18 (72.2 %) MAG-CP
sites of the major provinces; one site declined a site visit
and it could not be arranged at a mutually convenient
time at 4 others. All but one site visit involved didactic
rounds and all involved an interactive session. The me-
dian attendance was 9, and ranged from 5–50.
Twelve of the eighteen sites completed the B&F survey,
5 (41.7 %) before the site visit. There was a median [IQR]
of 17 [15, 19] surveys completed for small, 14.5 [11, 18]
for medium, and 14.5 [13, 21] for large CPN sites.
 Characteristics of participants (Table 1)
Teela et al. BMC Pregnancy and Childbirth  (2015) 15:347 Page 4 of 13
Table 1 Characteristics of 1608 participants by type of KT method (N (%) or mean ± SD of column total unless otherwise specified)
e-learning module (N = 1274) Site visits (N = 146*) Barriers & Facilitators
Survey (N = 188†)
Health care provider type
Physicians 458 (35.9 %) 59 (40.4 %) 92 (48.9 %)
Maternal-Fetal Medicine - ‡ 18 33
General Obs/Gyn 168 26 37
General Practice 200 0 0
Anaesthesia 15 4 2
Pediatrics/Neonatology 75 11 11
Unclassified 0 0 9
Nurses 439 (34.5 %) 57 (39.0 %) 87 (46.3 %)
Registered nurse 412 56 80
Nurse practitioner 25 1 0
Licensed practical nurse 3 0 0
Unclassified 0 0 7
Other 177 (13.9 %) 20 (13.7 %) 7 (3.7 %)
Midwife 4 1 2
Medical resident 9 3 2
Medical student 7 1 0
Research staff 5 14 1
Pharmacist 150 1 1
Administration 2 0 1
Unclassified 200 (15.7 %) 10 (6.8 %) 2 (1.1 %)
Province/Territory
British Columbia 162 (12.7 %) 10 (6.8 %) 21 (11.2 %)
Alberta 234 (18.4 %) 80 (54.8 %) 15 (8.0 %)
Saskatchewan 45 (3.5 %) 8 (5.5 %) 16 (8.5 %)
Manitoba 50 (3.9 %) 0 0
Ontario 517 (40.6 %) 25 (17.1 %) 58 (30.9 %)
Quebec 87 (6.8 %) 5 (3.4 %) 14 (7.4 %)
Newfoundland 35 (2.7 %) 6 (4.1 %) 17 (9.0 %)
New Brunswick 82 (6.4 %) 12 (8.2 %)¶ 34 (18.1 %)
Nova Scotia 35 (2.7 %) 13 (6.9 %)
Prince Edward Island 6 (0.5 %) 0 0
Yukon 6 (0.5 %) 0 0
NWT 9 (0.7) 0 0
Nunavut 5 (0.4) 0 0
Unknown 1 (0.0 %) 0 0
Works in a tertiary perinatal unit 472 (37.0 %) 146 (100 %) 188 (100 %)
Small (<3000 del/yr) 128/472 (27.1 %) 13/146 (8.9 %) 51/188 (27.1 %)
Medium (3000–4999 del/yr) 52/472 (11.0 %) 48/146 (32.9 %) 29/188 (15.4 %)
Large (≥5000 del/yr) 291/472 (61.7 %) 85/146 (58.2 %) 108/188 (57.5 %)
Missing 1/472 (0.2 %) 0 0
NWT (Northwest Territories), Del (deliveries), KT (knowledge translation), Obs/Gyn (Obstetrics and Gynaecology)
Note that the total % is broken down in various ways; each area until a bolded row adds to 100 %
* 13 sites were covered by 10 sites visits, as three small sites joined the visit at a larger centre
† Questionnaires were completed at 12/18 MAG-CP sites
‡ Not available as an option in the e-learning module
¶ Representatives from New Brunswick and Nova Scotia attended the site visit in Nova Scotia
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There were 1608 responses in the three forms of KT:
1274 (79.2 %) respondents to the e-learning module
(Mar 2012–3), 146 (9.1 %) participants at 10 sites visits
(Mar-Dec/12), and 188 (11.7 %) respondents to the B&F
Survey from 12 sites (Jun/12-Mar/13).
Table 1 shows that physicians comprised the highest
percentage of respondents across each KT method,
followed by nurses and then by “other”; 200 (15.7 %) of
e-learning module respondents did not identify with a
health care provider type listed. As all project related
staff were included in the site visits, more research staff
participated in that format compared with the e-learning
module and B&F survey, which were largely distributed
to clinicians. The greatest number of pharmacist partici-
pants was seen in the e-learning module as this format
was accessible to all staff whereas the site visits and B&F
survey were more limited to clinicians ordering and
implementing the protocol, or directly involved in the
MAG-CP study. The greatest proportion of respondents
for the e-learning module and B&F survey were from
Ontario, and for the site visits, Alberta. Only the e-
learning module accessed individuals outside of tertiary
perinatal units. Small MAG-CP sites were underrepre-
sented at site visits, and for each KT method, most re-
spondents were from large perinatal centres.
 Costs
The cost for developing the e-learning module was
$10,000.00, which was a reduced rate provided for work-
ing collaboratively with SOGC. The total cost of trans-
portation and accommodations to conduct the site visits
was $17,417.08, approximately $1,750.00 per visit. Costs
related to the B&F survey were assumed to be negligible
(see Methods).
 Barriers identified (Table 2)
By all KT methods, individual-level barriers were very
common, particularly inadequate knowledge and under-
standing, and fears. Some participants described multiple
barriers while others did not mention any, leading to a
discordance in response totals for Table 2 compared
with overall participation listed per method in Table 1.
Inadequate knowledge was identified in the e-learning
module as relating to others most often (“Not all staff
are informed of the standards” – RN, Ontario), versus to
self most often in the B&F survey (18/35, 51.4 % relevant
responses, 13 of which came from individuals who com-
pleted the B&F survey prior to the site visit. “I need a
course on it or guideline” – Physician, New Brunswick).
At site visits, the report did not contain sufficient detail
about who was lacking knowledge (self versus others).
Evidence concerns with regards to sufficiency and
validity were most evident in response to the B&F
survey (“Evidence is suggestive, but not overwhelming
in terms of using” – Neonatologist, Nova Scotia), with
7/14 (50 %) of similar responses from individuals who
completed the survey prior to the site visit. 10/14 re-
sponses regarding evidence concerns were from RNs,
with OB/GYNs (2/14) and neonatologists (2/14) rep-
resented less. Both neonatologists and two nurses
who reported evidence concerns suggested a lack of
validity, whereas the rest of the responses (10/14)
were concerning the sufficiency of the evidence. Simi-
lar concerns were documented at site visits (“…vari-
able belief in the evidence, with some strong local
opinion leaders who philosophically questioned the
validity of meta-analysis in informing clinical practice
guidelines…” – site visit report, Alberta) and the e-
learning module (”I am concerned that MgSO4 is not
as benign as is described in the literature or this
document”). Fears were commonly reported across all
KT methods, with the fear of adverse effects of
MgSO4 most often reported. The site visits offered
the broadest variety of distinct fears, being the only
format to include ‘fear of medication error’ specific-
ally. The e-learning module offered the least variety
of fears, with only ‘fear of adverse effects of MgSO4’
identified. Stated unsupported attitudes referred nearly
always to others (“Some ObGyn are close-minded” –
Nurse, Quebec), and the richness of responses in this
sub-node in the e-learning module and B&F survey
enabled identification of similar concerns between
professional groups at 3/10 (30 %) site visits at Western
and Eastern Canadian locations.
Institutional-level barriers were also commonly
expressed, though less so in the B&F survey relative
to the other formats. Timing and transport issues
around MgSO4 administration, as well as resource
constraints on busy delivery suites were detailed most
commonly, followed by the need for policy develop-
ment and implementation.
Social-level barriers were uncommon throughout, but
most were reported in the B&F survey, particularly a
lack of provider-institutional consensus.
 Facilitators (Table 3)
Facilitators of guideline adoption were included specific-
ally for discussion at the site visits and the B&F survey,
but not in the e-learning module which was developed
first. Some participants described multiple facilitators
while others did not mention any, leading to a discordance
in response totals for Table 3 compared with overall par-
ticipation listed per method in Table 1.
Institutional-level facilitators that were most commonly
reported included: facility characteristics, particularly a
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supportive institutional culture and evidence-based
practice and education and professional development,
followed by policies and protocols. Experience and
comfort with use of MgSO4 for use in pre-eclampsia/
eclampsia was more frequently reported as a facilitator
than a barrier, whereas inadequate knowledge regarding
neuroprotection was more often a barrier. Few respon-
dents identified a local champion/opinion leader as im-
portant. Individual- and social-level facilitators were
less commonly identified. For both formats, patient-
voice was seen as a facilitator rather than a barrier to
administration of MgSO4 for neuroprotection, despite
fears of negative side effects on the patient being listed
as a barrier.
 Nature of the knowledge needed (Table 4)
As inadequate knowledge was identified as a barrier to
implementation, all three KT formats contained rich
information on the nature of the knowledge gaps. We
report these separately as overall lessons.
Issues around how to administer MgSO4 for fetal
neuroprotection came up most frequently in all KT
methods, particularly so in site visit discussions. Most
commonly, respondents identified the following as-
pects of administration as requiring clarification: eli-
gibility (i.e., diagnosing threatened vs. imminent
preterm birth), timing of administration relative to
delivery, standards of practice, policies and protocols,
and the gestational age for eligibility. The variety of
responses was richest for the e-learning module (9
sub-nodes) and site visits (8 sub-nodes) compared
with the B&F survey (5 sub-nodes).
Side effects and risks were commonly identified as
a learning need by respondents, particularly in the e-
learning module (5 sub-nodes and 4 sub-sub-nodes)
and site visits (3 sub-nodes and 3 sub-sub-nodes)
compared with the B&F survey (1 sub-node and 1
Table 2 Barriers to use of MgSO4 for fetal neuroprotection (N (%) responses for all responses that relate to barriers)
Nodes Sub-nodes e-learning module
(N = 119)
Site visits
(N = 92)
Barriers & Facilitators
Survey (N = 147)
Individual-level 51 (42.9 %) 47 (51.1 %) 86 (58.5 %)
Unsupportive attitudes and beliefs 12 (10.1 %) 3 (3.3 %) 12 (8.2 %)
Not within provider’s control 4 (3.4 %) 0 2 (1.4 %)
No experience 3 (2.5 %) 1 (1.1 %) 3 (2.0 %)
Inadequate knowledge and understanding Overall 15 (12.6 %) 18 (19.6 %) 35 (23.8 %)
In self 0 3 18
In others 13 4 9
Unclear who lacks knowledge 2 11 8
Forgetting to administer MgSO4 1 (0.8 %) 1 (1.1 %) 3 (2.0 %)
Fears Overall 14 (11.8 %) 16 (17.4 %) 13 (8.8 %)
Legal 0 2 3
Medication error 0 2 0
Adverse effects of withholding MgSO4 0 3 5
Adverse effects of MgSO4 14 9 5
Failure to implement guidelines 0 1 (1.1 %)) 4 (2.7 %)
Evidence concerns (sufficiency and validity) 2 (1.7 %) 7 (7.6 %) 14 (9.5 %)
Institutional-level 64 (53.8 %) 34 (37.0 %) 40 (27.2 %)
Unsupportive institutional culture 2 (1.7 %) 3 (3.3 %) 3 (2.0 %)
Timing and transport 20 (16.8 %) 17 (18.5 %) 6 (4.1 %)
Resource constraints 31 (25.2 %) 12 (13.0 %) 20 (13.6 %)
Policy development and implementation 11 (9.2 %) 2 (12.0 %) 11 (7.5 %)
Social-level 4 (3.4 %) 11 (12.0 %) 21 (14.3 %)
Lack of provider-institutional consensus 1 (0.8 %) 4 (4.3 %) 15 (10.2 %)
Inadequate interprovider communication 0 7 (7.6 %) 5 (3.4 %)
Educating patients 3 (2.5 %) 0 1 (0.7 %)
MgSO4 (magnesium sulphate)
Note that the total % is broken down in various ways; each area until a bolded row adds to the % listed in the bolded row
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sub-sub-node). Knowledge needed regarding adverse
effects focused primarily on the neonate. The follow-
ing comments illustrate the variety of detail observed.
“When neonatal respiratory depression occurs as a
suspected result of maternal magnesium sulfate
administration, is calcium gluconate recommended to
assist in resuscitation, or would that counteract the
effects?” – RN, e-learning module
“The relationship between maternal dosing and the
potential impact on fetal heart rate variability.
Specifically, would 2 g/hr have an impact on FHR
variability.” – Site visit report, Saskatchewan
“Follow-up of patient care – mother and neonate –
statistics if possible” – Physician, B&F survey
While many respondents specified that further know-
ledge and/or research is needed, more than 10 % of re-
sponses from the e-learning module and B&F survey
identified “further research” as being needed without
identifying a research question.
 Comparison of the three KT methods (Table 5)
No one KT method was superior to the others by
all criteria. The e-learning module reached the widest
audience of health care providers, the site visits pro-
vided opportunity for iterative dialogue, and the B&F
survey was the cheapest. However, although the var-
iety of barriers identified was greatest for the site
visits, the B&F survey provided more information
around social-level barriers. The type of knowledge
needed was further defined by the e-learning module
and B&F surveys. Also, facilitator type differed by KT
method.
Discussion
Our findings
Of the three KT approaches taken in our managed
KT project MAG-CP, not surprisingly, the online e-
Table 3 Facilitators of use of MgSO4 for fetal neuroprotection (N (%) responses for all responses that relate to facilitators)*
Nodes Sub-nodes Site visits (N = 128) Barriers & Facilitators
Survey (N = 171)
Individual-level 17 (13.3 %) 38 (22.2 %)
Supportive attitudes and beliefs 4 (3.1 %) 9 (5.3 %)
Knowledge and understanding 8 (6.3 %) 15 (8.8 %)
Early adopters/mobilizers 1 (0.8 %) 9 (5.3 %)
Comfort/experience using MgSO4 4 (3.1 %) 5 (2.9 %)
Institutional-level 80 (62.5 %) 107 (62.6 %)
Policies and protocols Overall 34 (26.6 %) 26 (15.2 %)
Pre-printed orders for MgSO4 use 5 6
Pre-mixed bags of MgSO4 8 2
Mechanism for audit and feedback 8 3
Unclassifiable 13 15
Local champion/opinion leader 8 (6.3 %) 11 (6.4 %)
Facility characteristics Overall 38 (29.7 %) 70 (40.9 %)
Supportive institutional culture/evidence-based 18 38
Patient load 3 10
Human resource capacity 5 4
Education and professional development 12 18
Social-level 31 (24.2 %) 26 (15.2 %)
Patient voice/awareness 4 (3.1 %) 2 (1.2 %)
Knowledge translation 17 (13.3 %) 5 (2.9 %)
Community support 2 (1.6 %) 0
Communication and collaboration 8 (6.3 %) 19 (11.1 %)
* When the e-learning module was designed, a specific exploration of facilitators was not planned and therefore, undertaken
Response about general policy/protocol and not specific to pre-printed orders, pre-printed bags, or audit/feedback
Note that the total % is broken down in various ways; each area until a bolded row adds to the % listed in the bolded row
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learning module reached a greater number of individ-
uals, but all three KT methods accessed views from
similar types of care providers. In part, this may
have been a result of the Central MAG-CP directive
that site visit members and respondents to the B&F
survey should be a representative population.
No individual KT method was superior to the others
in terms of the barriers and facilitators identified, and
Table 4 Responses for ‘knowledge needed’ (N (%) responses) for all responses that relate to knowledge needed)
Nodes Sub-nodes Sub-sub-node e-learning module
(N = 188)
Site visits
(N = 85)
Barriers & Facilitators
Survey (N = 65)
Mechanism of action 11 (5.9 %) 2 (2.4 %) 17 (26.2 %)
Administration Overall 47 (25.0 %) 61
(71.8 %)
26 (40.0 %)
Transfer 0 2 0
Threatened preterm labour vs. imminent preterm birth 3 10 0
Timing of administration 6 9 7
Standards of practice 4 10 2
Re-treatment 0 7 3
Pre-printed orders 1 0 0
Policies and protocols 8 3 7
Multiple pregnancies 1 0 0
Gestational age 8 7 2
Drug interactions 5 0 0
Contraindications 1 2 0
Unclassified 10 11 5
Side effects and
risks
Overall 26 (13.8 %) 16
(18.8 %)
6 (9.2 %)
Rapid delivery 1 0 0
Overuse 1 1 0
Interventions as a result of MgSO4 3 0 0
Increased monitoring needed 5 0 0
Adverse physiological effects –
neonate
Toxicity 3 1 0
Problems with feeding 1 0 0
Neonatal respiratory
depression
6 3 0
Long-term effects 0 1 2
Adverse neurological effects 1 0 0
Adverse physiological effects – general
(unspecified maternal/neonate)
0 7 0
Unclassified 4 2 4
KT tools Overall 7 (3.7 %) 0 3 (4.6 %)
Audit and feedback 1 0 0
Unclassified 6 0 3
Research Overall 46 (24.5 %) 5 (5.9 %) 13 (20.0 %)
Further research 33 3 5
Evidence to date 6 1 7
Unclassifiable 7 1 1
Other uses and topics (not MgSO4 for fetal neuroprotection) 30 (16.0 %) 1 (1.2 %) 0
None stated 21 (11.2 %) 0 0
MgSO4 (magnesium sulphate)
Note that the total is broken down in various ways; each area until a bolded row adds to the total n listed in the bolded row
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knowledge needed determined by rates and richness of
qualitative data. Although we did not see a drop in
length/quality of quotes with the rise in breadth/variety,
the site visits provided the most detailed information
about individual and organizational barriers, and the
‘Barriers and Facilitators’ on-site survey more detail
about social level barriers. The facilitators identified var-
ied by KT method. The type of background, evidential,
clinical, and judgment knowledge needed was further
defined by the e-learning module and surveys.
It is important to recognize the advantages and restric-
tions associated with each KT strategy. The e-learning
module provided intellectual stimulation that the learner
could move through at his/her own pace, in the form of
online education documents, case studies, questions and
answers, and tools, all presented prior to the discussion
forum which sought learners’ feedback; this may have
prompted the wide variety of information obtained, sug-
gesting that online KT is effective. Although the site
visits started with a presentation of the evidence, it was
limited by time and event structure (usually a didactic
round). However, issues raised in the site visit report
may have been a summary of a larger conversation,
stimulated by the facilitators having the opportunity to
ask probing questions to clarify views and enrich the dis-
cussion. Also, there was no limit on the range of topics
discussed in contrast with the e-learning module and
B&F survey, which had pre-set questions, such as the e-
learning module with a more restricted interest in ‘fears’.
On the other hand, statements from the e-learning mod-
ule and B&F survey are direct quotes in response to
open text boxes, without imposing limitations on time
or space (although other limitations may have been at
play, such as personal schedules or end-of-survey
fatigue). These formats have the additional potential ad-
vantage of anonymity, possibly a reason for fewer com-
ments about “unsupportive attitudes and beliefs” in site
visit reports and more about social barriers on the B&F
survey. This would support having an anonymous com-
ponent to the KT in the future.
How findings compare with existing literature
We used evidence-based methods specific to clinical
guideline implementation such as KT lead by a clinician
to allow for clinician-to-clinician transfer [29–31], the
inclusion of professional decision-support tools [32, 33],
presentation of up-to-date systematic reviews rather than
only individual research studies [29], and the development
of interactive, multi-disciplinary KT interventions as
opposed to simply passive interventions [32].
The coding of barriers to guideline implementation that
we saw in this project parallel those found in the literature
for similar implementation and KT studies [29, 34].
Within the clinical practice field, differences based on
context have been noted in success of KT, indicating
benefit in designing context-specific KT interventions.
In the field of obstetrics, for example, one study con-
cluded that a multifaceted strategy based on audit and
feedback that is facilitated by local opinion leaders may
be the most effective behaviour change than any single
KT intervention [35]. However, even when designed for
the appropriate clinical context, KT interventions can be
successful in one hospital but not another [36], demon-
strating perhaps that further nuances are at play. Indeed,
the success of KT is contingent on factors at multiple
levels – broad environment, health care system, health
care institution, health care team, individual health care
provider, and patient – and may run into challenges at
Table 5 Summary of key results / findings unique to each KT format
e-learning module Site visits B&F survey
Respondents accessed • Reached the largest number of
participants across the widest
geographic area
• Reached fewer practitioners,
but of a similar scope in terms
of roles within health care
• Most limited in terms of ‘other’ non-
physician and non-nurse respondents
Barriers • Most restricted breadth of fears listed
• Insufficient knowledge most often
identified in others
• Greatest spread of barriers across
individual, institutional, and social levels
• More social-level barriers compared
with other formats
• Insufficient knowledge most often
identified in respondent
Facilitators -* • Institutional-level most cited, followed
by social-level
• Institutional-level most cited, followed
by individual-level
Knowledge needed • Greatest number of responses calling
for further research
• Information on administration cited
most often
• Least amount of information provided
Method • One-way • Two-way • One-way
Approximate cost • $10,000 • $17,500 (total) or $1750 per visit† • Negligible (assumption)†
B&F (Barriers and Facilitators)
* Facilitators were not included in the e-learning module format which was developed first
† As academic health care centre employees, salaries were considered to cover educational activities such as for MAG-CP. Site visit costs were based on
travel expenses
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any of these levels [37]. As we saw in our analyses, KT
success is also influenced by factors outside the individ-
ual’s control such as facility and organizational support,
and the scope of practice for that individual’s role [38].
Factors related to the learner specifically [38–40], as well
as the change being proposed also influence the outcomes
of KT interventions. A clear clinical improvement over
current behaviour [41] and simplicity versus complexity of
the proposed change [37, 41–43] help bring about success.
The barriers and facilitators noted by respondents across
our three KT formats reflect these complexities.
Strengths and limitations
The knowledge translation portion of the MAG-CP pro-
ject has a number of strengths. We used a multi-format
approach to the same information, with potential over-
lap of participants, to allow for representation of differ-
ent learning styles. Our approach also included clear
decision-making tools, which the literature has shown to
be helpful in guideline implementation post introduction
[17]. Our knowledge translation plan was flexible and
allowed for the addition of an examination of facilitators
to guideline adoption after the e-learning module had
been launched, as well as ongoing revision and redistri-
bution of the B&F survey. We were able to interact with
a large number and variety of health care workers, cov-
ering coast to coast geographic representation across
Canada (4.5 hours of time zones), and reaching what we
determined was saturation (for all KT formats) in a rela-
tively short period of time (March 2012 – March 2013).
This project has limitations. First, our data collection
does not allow for us to adequately analyze overlap among
respondents who may have participated in all three KT
strategies, or distinguish who among the B&F survey re-
spondents who indicated ‘inadequate knowledge and un-
derstanding’ after occurrence of their site’s visit actually
attended that visit. Second, as the e-learning module was
presented as aggregate data and the site visit reports were
compiled as comprehensive reports (as opposed to verba-
tim transcripts), we were unable to analyze respondent-
specific trends across questions and topics in these
formats. Third, a limitation of this study is under-
representation of some healthcare provider types whose
experience and opinions are relevant. For example, respira-
tory therapists are not responsible for the decision to ad-
minister MgSO4 during labour, but may see effects of
interventions on newborns, infants, and children; midwives
are not well represented compared with physicians, but
may be working with and providing education for women
for whom this intervention is relevant. Fourth, the addition
of facilitators (as opposed to just barriers) to the data col-
lection was decided after the e-learning module had been
launched, preventing comparison of facilitators across all
three KT formats. Finally, site visit reports were written as
a discussion summary by the Central MAG-CP Team as
opposed to direct or aggregate responses from participants
seen in the other two formats, which may introduce obser-
ver bias, and made comparison across formats less direct.
Conclusions
With each of the e-learning module, site visits, and local
B&F survey, we found advantages and disadvantages such
that none was deemed superior for comprehensiveness of
respondents reached, barriers and facilitators identified,
knowledge felt that they still required, and cost. We would
recommend taking all such approaches in future perinatal
KT endeavours, although the site visits could be led by
local teams to decrease cost.
This information has been given back to sites
through presentations and teleconferences with cen-
tres. Implementation strategies have been modified to
barriers identified, such as creation of new practice
tools and reminders. Comparison with data audit is
currently ongoing. As audit and feedback are essential
parts of the process by which evidence to practice
gaps are closed [17], MAG-CP project is continuing
the iterative KT process described in this paper in
parallel with tracking of MgSO4 use for fetal neuro-
protection and maternal and child outcomes until
September 2015.
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